Fact CheckerSign in

NCT07855718Not yet recruiting

Serum Soluble BCMA as a Non-Invasive Marker in Multiple Myeloma

Serum Soluble B-cell Maturation Antigen as a Non-Invasive Marker in Multiple Myeloma

Source: ClinicalTrials.gov · Last updated 2 Oct 2026

Brief summary (registry, in English)

This prospective study aims to investigate serum soluble B-cell maturation antigen (sBCMA) as a non-invasive marker in patients with multiple myeloma and to compare its levels with healthy controls.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
90 (estimated)
First submitted
28 Sept 2026
Start date
30 Sept 2026
Primary completion date
30 Sept 2027
Lead sponsor
Assiut University
NCT number
NCT07855718

What you commit to

  • Study type: Observational
  • Planned participants: 90
  • From 30 Sept 2026 to the primary completion date, 30 Sept 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • \- Other active malignancies or autoimmune diseases
  • Active infection or inflammatory disease at sampling

Lab values

  • Severe renal impairment (serum creatinine \> 3.0 mg/dL)

Other

  • Pregnancy or lactation

Who the study is looking for

  • Group 1 (Newly Diagnosed MM):
  • Age 18 years or older
  • Newly diagnosed multiple myeloma according to WHO 2022 criteria
  • Pretreatment at time of sample collection
    • Group 2 (Relapsed/Refractory MM):
  • Age 18 years or older
  • Confirmed multiple myeloma with documented relapse or refractory disease after at least one prior line of therapy
    • Group 3 (Controls):
  • Age 18 years or older
  • Healthy volunteers with normal CBC and renal function
  • Age and sex matched to patient groups

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.